Lexeo Therapeutics Starts $100 Million U.S. IPO Effort (Pending:LXEO)

Scientist working in the laboratory


A Quick Take On Lexeo Therapeutics, Inc.

Lexeo Therapeutics, Inc. (LXEO) has filed to raise $100 million in an IPO of its common stock, according to an SEC S-1 registration statement.

The clinical-stage biopharma is developing treatments for various

Source link

Leave a Reply

Your email address will not be published. Required fields are marked *